Inclusion Criteria:  Women diagnosed with missed miscarriage in the first 13+6 weeks of pregnancy opting for medical management Age 18 years and older Intra-uterine pregnancy Hemodynamically stable patient No signs of infection No signs of incomplete miscarriage Willing and able to give informed consent  Exclusion Criteria:  Women opting for alternative methods of miscarriage management (expectant or surgical) Diagnosis of incomplete miscarriage Life threatening bleeding Hemodynamically unstable patient Contraindications to mifepristone or misoprostol use for example chronic adrenal failure, known hypersensitivity to either drug, haemorrhagic disorders and anticoagulant therapy, prosthetic heart valve or history of endocarditis, existing cardiovascular disease, severe asthma uncontrolled by therapy or inherited porphyria Previous participation in this trial Unable to give informed consent